Results 131 to 140 of about 96,425 (243)

Expression of Cyclin D1, p53, and Tumor-Associated Tissue Eosinophils in Different Grades of Oral Squamous Cell Carcinoma. [PDF]

Cureus
Habib M, Rauf M, Omair S, Chaudry SS, Khan AR, Ahmad A, Sheikh A.   +6 more
europepmc   +1 more source

DACH1 Is a Cell Fate Determination Factor That Inhibits Cyclin D1 and Breast Tumor Growth

, 2006
Kongming Wu, Anping Li, Mahadev Rao, Manran Liu, Vernon Dailey, Ying Yang, Dolores Di Vizio, Chenguang Wang, Michael P. Lisanti, Guido Sauter, Robert G. Russell, Aleš Cvekl, Richard G. Pestell   +12 more
openalex   +1 more source

WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase [PDF]

, 2015
Jen‐Tai Lin, Hao‐Yi Li, Nan‐Shan Chang, Cheng‐Han Lin, Yu‐Chia Chen, Pei‐Jung Lu   +5 more
openalex   +1 more source

PLK4 is a potential therapeutic target in nonmelanoma skin cancers: Evidence from molecular and in vivo studies

Photochemistry and Photobiology, EarlyView.
Exposure to solar ultraviolet radiation is the main etiologic driver of nonmelanoma skin cancers (NMSCs), including basal cell (BCC) and cutaneous squamous cell carcinomas (cSCC), which are the most prevalent types of cancers in the US. In this study, we demonstrate that the serine/threonine kinase Polo‐like kinase 4 (PLK4) is overexpressed in NMSCs ...
Mary A. Ndiaye, Debra R. Garvey, Gagan Chhabra, Chandra K. Singh, Minakshi Nihal, Nihal Ahmad   +5 more
wiley   +1 more source

Expression of Concern: Regulation of Glioblastoma Progression by Cord Blood Stem Cells Is Mediated by Downregulation of Cyclin D1. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Table S3 from Breast Cancer Mutations <i>HER2^V777L</i> and <i>PIK3CA^H1047R</i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

Xiaoqing Cheng, Yirui Sun, Maureen Highkin, Nagalaxmi Vemalapally, Xiaohua Jin, Brandon Zhou, Julie L. Prior, Ashley R. Tipton, Shunqiang Li, Anton Iliuk, Samuel Achilefu, Ian S. Hagemann, John R. Edwards, Ron Bose   +13 more
openalex   +1 more source

Harnessing blue light photobiomodulation for cancer therapy: Evidence from a systematic review

Photochemistry and Photobiology, EarlyView.
Conventional treatments for various types of cancer are often associated with tumor recurrence and aggressiveness. Photobiomodulation with blue light (BL; 450–470 nm) emerges as a promising alternative with antitumor effects. This systematic review, with 37 in vitro and in vivo studies from 2002 to 2024, revealed that BL reduces cell viability ...
Bárbara Evelyn Santos de Lima, Rebeca Barros Nascimento, Ana Paula Mariano Santos Ginez, Maria Stella Moreira, Rebeca Boltes Cecatto, Rodrigo Labat Marcos, Maria Fernanda Setúbal Destro Rodrigues   +6 more
wiley   +1 more source

Elevated SNHG15 empowers keratinocytes hyperproliferation through activation of STAT3/Cyclin D1 axis in psoriasis. [PDF]

Acta Pharm Sin B
Tang L, Li G, Chang J, Xian H, Liu Y, Lin L, Dai Z, Liu Z, Qiu X, Zhang B, Su Z, Feng B, Zhu Y, Wang M, Chen Y, Liu H, Wu D, Li C, Zhao J, Li M, Zhu Y, Xie X, Deng H, Ye S, Fan S, Bi H, Lu C, Zheng G.   +27 more
europepmc   +1 more source

Downregulation of Cyclin D1 by Sophorae Flos through Proteasomal Degradation in Human Colorectal Cancer Cells

, 2015
Jin Wook Lee, Gwang Hun Park, Hyun Ji Eo, Jin Boo Jeong   +3 more
openalex   +2 more sources

The Protein-tyrosine Phosphatase SHP-2 Is Required during Angiotensin II-mediated Activation of Cyclin D1 Promoter in CHO-AT1A Cells [PDF]

, 2000
Laurent Guillemot, A. Levy, Zhizhuang Joe Zhao, G. Béréziat, Bernard Rothhut   +4 more
openalex   +1 more source